BP
Boris Pasche, M.D., Ph.D.
Co-inventor, Co-founder, CEO (TheraBionic Inc.), Geschäftsführer (TheraBionic GmbH)
TheraBionicTherapeutic Areas
TheraBionic Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TheraBionic P1 | Advanced Hepatocellular Carcinoma (HCC) | Approved/Commercial |